Management
Dr Mark Landy – President,Chief Executive Officer and Director
Dr. Landy is widely recognized for his financial acumen and proven accomplishments as a Wall Street equity analyst with diverse sell-side, buy-side and venture capital experience. He most recently distinguished himself as the Senior Research Analyst of Medical Supplies and Devices at Susquehanna Financial Group, where he was voted the firm’s top-ranked healthcare analyst by institutional clients in both 2004 and 2005.In addition, Dr. Landy is a familiar financial pundit in the financial media, who has made frequent appearances on CNBC, Reuters, Dow Jones, Bloomberg, and in The Wall Street Journal and Business Week, among other outlets. Among other highlights in Dr. Landy’s career, he was Director and Senior Research Analyst of Medical Devices at the Boston, MA-based healthcare boutique, Leerink Swann & Company. During his tenure at Leerink Swann the Firm’s Medical Supplies and Device Team achieve the #1 ranking in Institutional Investor Magazine’s “Best of the Boutiques: Medical Supplies and Devices” poll for both 2002 and 2003.Dr. Landy holds a degree in business from the Wharton School of Business at the University of Pennsylvania, and also holds the degree equivalent of Doctor of Dental Surgery from the University of the Witwatersrand, in Johannesburg, South Africa. He spent three years in London, U.K., in private practice focusing on posttraumatic facial reconstructive surgery. He has had articles published in both business and health care journals.
Alan P. Lindsay – Chairman and Director
Mr. Lindsay has been Chairman, President, Chief Executive Officer, and Director of MIVT since October 2001. He has experience in building and directing public companies for the past 15 years. From 1991 to 2000, Mr. Lindsay was Chairman, President and Chief Executive Officer of a base metals exploration company that he co-founded and took public on the Toronto (TSX) and American Stock Exchange (AMEX). Mr. Lindsay was also Chairman of the Board of GeneMax Pharmaceuticals Inc., a company he co-founded in 1999. He was previously responsible for building a significant business and marketing organization in Vancouver, BC, for Manulife Financial, a major international financial services corporation. Mr. Lindsay has been responsible for the acquisition of the Company's technology, for financing, corporate development and the strategic vision of the Company.
Patrick A. McGowan, Executive Vice President, Chief Financial Officer, and Director
Mr. McGowan has extensive experience in senior management in both private and public companies. At MIVT, he oversees daily operations and manages corporate matters, which include regulatory filings, strategic planning, and negotiations with legal counsel, auditors, and financial institutions. Mr. McGowan has previous management experience with Flecto Company and McNeil Laboratories, a subsidiary of Johnson & Johnson, where he was a member of the team that introduced Tylenol, anesthetic and psychotropic drugs to the market. He is a frequent lecturer at the Canadian Management Association and a guest lecturer at international corporate conferences. Mr. McGowan holds a B.Sc. degree in finance and economics and an MBA degree.
